Development and Validation of a Nomogram for Predicting the 6-months Survival Rate of Patients Undergoing Incident Hemodialysis in China
Overview
Affiliations
Background: The all-cause mortality of patients undergoing hemodialysis (HD) is higher than in the general population. The first 6 months after dialysis are important for new patients. The aim of this study was to develop and validate a nomogram for predicting the 6-month survival rate of HD patients.
Methods: A prediction model was constructed using a training cohort of 679 HD patients. Multivariate Cox regression analyses were performed to identify predictive factors. The identified factors were used to establish a nomogram. The performance of the nomogram was assessed using the C-index and calibration plots. The nomogram was validated by performing discrimination and calibration tests on an additional cohort of 173 HD patients.
Results: During a follow-up period of six months, 47 and 16 deaths occurred in the training cohort and validation cohort, respectively, representing a mortality rate of 7.3% and 9.2%, respectively. The nomogram comprised five commonly available predictors: age, temporary dialysis catheter, intradialytic hypotension, use of ACEi or ARB, and use of loop diuretics. The nomogram showed good discrimination in the training cohort [C-index 0.775(0.693-0.857)] and validation cohort [C-index 0.758(0.677-0.836)], as well as good calibration, indicating that the performance of the nomogram was good. The total score point was then divided into two risk classifications: low risk (0-90 points) and high risk (≥ 91 points). Further analysis showed that all-cause mortality was significantly different between the high-risk group and the low-risk group.
Conclusions: The constructed nomogram accurately predicted the 6-month survival rate of HD patients, and thus it can be used in clinical decision-making.
Liu S, Wang Y, He X, Li X Diabetes Metab Syndr Obes. 2024; 17:4825-4841.
PMID: 39717233 PMC: 11665172. DOI: 10.2147/DMSO.S484041.
Gu W, Zhang M, Liang C, Ma S, Wang X, Yuan H Blood Purif. 2024; 53(9):755-767.
PMID: 38901418 PMC: 11397407. DOI: 10.1159/000539786.
Qin M, Yang Y, Dai L, Ding J, Zha Y, Yuan J Sci Rep. 2024; 14(1):6760.
PMID: 38514675 PMC: 10958022. DOI: 10.1038/s41598-024-55161-y.